Am. J. Respir. Crit. Care Med., Volume 162, Number 1, July 2000, 258-263

Serum Levels of Surfactant Proteins A and D Are Useful Biomarkers for Interstitial Lung Disease in Patients with Progressive Systemic Sclerosis

HIROKI TAKAHASHI, YOSHIO KUROKI, HIROSHI TANAKA, TSUKASA SAITO, KEIZO KUROKAWA, HIROFUMI CHIBA, AKIRA SAGAWA, HISATO NAGAE, and SHOSAKU ABE

Third Department of Internal Medicine and Department of Biochemistry, Sapporo Medical University School of Medicine, Sapporo, Japan; Sapporo Yamanoue Hospital, Sapporo, Japan; and Immunology Laboratory, Diagnostics Division, Yamasa Corporation, Choshi, Japan

To find a less-invasive and lung-specific clinical biomarker, we measured serum levels of surfactant proteins A and D (SP-A and SP-D) by sandwich enzyme-linked immunosorbent assays in 42 patients with progressive systemic sclerosis (PSS) to evaluate their significance in relation to the presence of interstitial lung disease (ILD) and to assess their diagnostic merits. The patients were divided into two groups based on findings by chest computed tomography (CT): 30 patients with ILD (CT-positive ILD group), and 12 patients without any lung abnormalities (CT-negative ILD group). The CT-positive ILD group was further divided into two groups: 24 patients with ILD detectable by chest plain radiography (X-ray-positive ILD group) and six patients with ILD showing no abnormality (X-ray-negative ILD group). The levels of SP-A and SP-D in sera were significantly higher in the CT-positive ILD group than in the CT-negative ILD group. They were also significantly higher in the X-ray-positive ILD group than in the CT-negative ILD group. In the X-ray-negative ILD group, their levels were higher than those of the CT-negative ILD group. We next estimated sensitivity and specificity of SP-A, SP-D, and X-ray for detecting ILD on CT. Sensitivity of SP-D was high (77%) as well as that of X-ray (80%), whereas SP-A showed a low sensitivity (33%). Remarkably, five of six patients in the X-ray-negative ILD group showed SP-D concentrations over its cut-off level, thereby demonstrating that an SP-D assay contributes to the detection of ILD overlooked by X-ray. Moreover, a combination of X-ray and SP-D dramatically increases sensitivity to 97%. Specificity of SP-A, SP-D, and X-ray to the CT-negative ILD group was 100%, 83%, and 100%, respectively. In conclusion, this study indicates that elevated levels of serum SP-A and SP-D reflect well the presence of ILD and that the combination of SP-D and X-ray contributes to reduce the risk of clinicians overlooking ILD complicated by PSS, although a repetition in another set of subjects is needed to confirm these indications.

This article has been cited by other articles:

				K. M. Antoniou, G. Margaritopoulos, F. Economidou, and N. M. Siafakas Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement Eur. Respir. J., April 1, 2009; 33(4): 882 - 896. [Abstract] [Full Text] [PDF]

				J. Wang, K. Edeen, R. Manzer, Y. Chang, S. Wang, X. Chen, C.J. Funk, G. P. Cosgrove, X. Fang, and R. J. Mason Differentiated Human Alveolar Epithelial Cells and Reversibility of their Phenotype In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 661 - 668. [Abstract] [Full Text] [PDF]

				G. L. Sorensen, J. v. B. Hjelmborg, K. O. Kyvik, M. Fenger, A. Hoj, C. Bendixen, T. I. A. Sorensen, and U. Holmskov Genetic and environmental influences of surfactant protein D serum levels Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L1010 - L1017. [Abstract] [Full Text] [PDF]

				Q. A. Al-Salmi, J. N. Walter, G. N. Colasurdo, M. M. Sockrider, E. O. Smith, H. Takahashi, and L. L. Fan Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease Chest, January 1, 2005; 127(1): 403 - 407. [Abstract] [Full Text] [PDF]

				D. S. Phelps, T. M. Umstead, M. Mejia, G. Carrillo, A. Pardo, and M. Selman Increased Surfactant Protein-A Levels in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis Chest, February 1, 2004; 125(2): 617 - 625. [Abstract] [Full Text] [PDF]

				M. Krane and M. Griese Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis Eur. Respir. J., October 1, 2003; 22(4): 592 - 595. [Abstract] [Full Text] [PDF]

				K. Takeda, N. Miyahara, Y.-H. Rha, C. Taube, E.-S. Yang, A. Joetham, T. Kodama, A. M. Balhorn, A. Dakhama, C. Duez, et al. Surfactant Protein D Regulates Airway Function and Allergic Inflammation through Modulation of Macrophage Function Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 783 - 789. [Abstract] [Full Text] [PDF]

				F. Zhang, W. Pao, S. M. Umphress, S. B. Jakowlew, A. M. Meyer, L. D. Dwyer-Nield, L. D. Nielsen, K. Takeda, E. W. Gelfand, J. H. Fisher, et al. Serum Levels of Surfactant Protein D Are Increased in Mice with Lung Tumors Cancer Res., September 15, 2003; 63(18): 5889 - 5894. [Abstract] [Full Text] [PDF]

				C. G. De Pasquale, A. D. Bersten, I. R. Doyle, P. E. Aylward, and L. F. Arnolda Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2136 - H2145. [Abstract] [Full Text] [PDF]

				H Ishii, H Mukae, J Kadota, H Kaida, T Nagata, K Abe, S Matsukura, and S Kohno High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia Thorax, January 1, 2003; 58(1): 52 - 57. [Abstract] [Full Text] [PDF]

				K.E. Greene, T.E. King Jr, Y. Kuroki, B. Bucher-Bartelson, G.W. Hunninghake, L.S. Newman, H. Nagae, and R.J. Mason Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis Eur. Respir. J., March 1, 2002; 19(3): 439 - 446. [Abstract] [Full Text] [PDF]

				H. OHNISHI, A. YOKOYAMA, K. KONDO, H. HAMADA, M. ABE, K. NISHIMURA, K. HIWADA, and N. KOHNO Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 378 - 381. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				H. Takahashi, Y. Imai, T. Fujishima, M. Shiratori, S. Murakami, H. Chiba, H. Kon, Y. Kuroki, and S. Abe Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis Eur. Respir. J., March 1, 2001; 17(3): 481 - 487. [Abstract] [Full Text] [PDF]

				T. Pan, L. D. Nielsen, M. J. Allen, K. M. Shannon, J. M. Shannon, M. Selman, and Robert. J. Mason Serum SP-D is a marker of lung injury in rats Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L824 - L832. [Abstract] [Full Text] [PDF]